Condition
Prostate Cancer Stage III
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Not Yet Recruiting1
Withdrawn1
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07225309Not ApplicableNot Yet Recruiting
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
NCT03432780Phase 2UnknownPrimary
Radiation-hormone and Docetaxel VS Radiation-hormone in Patients With High-Risk Localized Prostate Cancer
NCT03514927Not ApplicableWithdrawn
High-Intensity Focused Ultrasound in Treating Participants With Intermediate and High-risk Prostate Cancer
Showing all 3 trials